Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Well-Respected Prosthodontist, Dr. David Zelby of Aesthetic & Implant Dentistry of Atlanta, is Featured in the September Issue of The Atlantan Magazine


News Image

It has been such a pleasure serving patients for all these years with excellence in dentistry. I am so honored to be recognized by The Atlantan with this accolade, says Dr. David Zelby

Dr. David Zelby, is recognized by The Atlantan as one of the city’s top leading and influential medical professionals in their September 2020 issue. Dr. Zelby of Aesthetic & Implant Dentistry of Atlanta is a prosthodontist, specializing in the aesthetic restoration and replacement of teeth, dental implants, veneers as well as cosmetic dentistry. As a leading prosthodontist, Dr. Zelby has years of extra training and is uniquely qualified to create restorations, such as crowns and bridges, that replicate the natural feel and appearance of your teeth. For the past 30 years, Dr. Zelby has been known around Atlanta as a compassionate and gifted cosmetic dentist and implant specialist, well-versed in both general and prosthodontic procedures. He skillfully blends art and advanced dental techniques, changing the smiles of thousands of his patients. David Zelby, DDS embarked his lifelong passion in perfecting dental techniques and changing the lives of patients by earning his general dental degree from the NYU School of Dentistry in 1974. After graduating, he spent one year in residency at French and Polyclinic Hospital in New York City and continued his education to become a certified prosthodontist at South Carolina College of Dental Medicine. After establishing his first clinic in Midtown, Atlanta, he moved his practice in 1992 to the Cobb Galleria Office Park and established Aesthetic & Implant Dentistry of Atlanta. He expanded his practice in 2010, building a new state-of-the art dental center. Dr. Zelby has shared his extensive knowledge by teaching at Emory University Dental School for 12 years and he is currently a clinical instructor of dentistry at Ben Massell Dental Clinic for Georgia Regents University School of Dental Medicine. Dr. Zelby is devoted to staying on top of scientific and technological developments in general and prosthetic dentistry. Public service is another hallmark of Dr. Zelby’s career, and he has been recognized on multiple occasions for his commitment to serving the underprivileged, including being given the title of “Honorary Senator” for the state of Georgia by Governor Casey Cagle in August of 2008.

“It has been such a pleasure serving patients for all these years with excellence in dentistry. I am so honored to be recognized by The Atlantan with this accolade,” says Dr. David Zelby

More about Aesthetic & Implant Dentistry of Atlanta:

Aesthetic & Implant Dentistry of Atlanta is located at 200 Galleria Pkwy SE, Suite 1830 in Atlanta, GA. Dr. David Zelby and his dental team are dedicated to providing outstanding service to every patient. They offer a full range of general and cosmetic dental services, from the latest aesthetic dental enhancements to the most complex full-mouth restorations.

For more information about Dr. Zelby and Aesthetic & Implant Dentistry of Atlanta please call 770-955-0550 or visit http://www.newsmileatlanta.com.

Share article on social media or email:

NYC-Based Dr. Gregory Levitin Recently Completed his 500th Balloon Sinuplasty Using Local Anesthesia


News Image

My balloon sinuplasty success rate for patients with chronic sinusitis is high, reducing sinus congestion, headaches, and recurrence of sinus infections. I’m very proud to have reached this major accomplishment, helping to treat over 500 patients with this in-office procedure, said Dr. Levitin.

Dr. Gregory Levitin recently reached a milestone performing his 500th in-office balloon sinuplasty using only local anesthesia. Balloon sinuplasty is a relatively new technology, providing quick and effective sinusitis relief with minimal discomfort. Dr. Levitin’s expertise using local anesthesia is a game-changer for patients compared to traditional sinus surgery. Patients are literally able to walk in and walk out of the office in 45 minutes, so there is no need to go to an operating room for general anesthesia or sedation.

The purpose of balloon sinuplasty treatment is to provide relief from symptoms caused by chronic sinus obstruction and nasal congestion by opening up the sinuses. Unlike conventional sinus surgery, it does not include removal of bone or tissue from the nose. The sinus passages are widened with a balloon catheter that is gently inserted and inflated in the nasal passages, and then carefully removed. Without any incisions or tissue removal, there is less bleeding, fewer risks, less postoperative pain, and a quicker recovery. When the balloon sinuplasty procedure is carried out by an experienced surgeon such as Dr. Gregory Levitin, this treatment is safe, avoids more invasive surgery, and provides lasting relief for many years. Patients who suffer from chronic sinusitis and are looking for a long-term solution to relieve their sinus pain and discomfort should be evaluated to see if they would benefit from the balloon sinuplasty procedure.

“My balloon sinuplasty success rate for patients with chronic sinusitis is high, reducing sinus congestion, headaches, and recurrence of sinus infections. I’m very proud to have reached this major accomplishment, helping to treat over 500 patients with this convenient, in-office procedure,” said Dr. Gregory Levitin.

More about Dr. Gregory Levitin:

Dr. Gregory Levitin, MD, FACS is a board certified Otolaryngologist-Head & Neck surgeon and a Fellow of the American Academy of Otolaryngology (AAO-HNS). He is also an Associate Clinical Professor in the Department of Otolaryngology at The New York Eye and Ear Infirmary of Mount Sinai. Dr. Levitin’s areas of expertise include office-based treatment for chronic sinusitis, allergic and chronic rhinitis, nasal valve collapse, nasal obstruction and snoring, and voice disorders.

Balloon sinuplasty has helped thousands of people have fewer sinus infections and reduce sinus symptoms, improving their health and comfort. Plan a visit today and let Dr. Levitin help you decide if this procedure would be right for you, or if another type of sinus or nasal treatment would better suit your needs.

For more information, please call 212-784-6643 to reach his Manhattan office/Columbus Circle, 200 W. 57th Street, Suite 1410, or visit http://www.sinusitistreatmentnyc.com.

Share article on social media or email:

Shady Grove Fertility Atlanta Welcomes Reproductive Endocrinologist Valerie Libby, M.D., to the Practice


SGF Atlanta welcomes reproductive endocrinologist Dr. Valerie Libby.

I am honored and thrilled to join SGF Atlanta. The first time I met with SGF, I learned about their core values of integrity, empathy, and increasing access to care—values directly aligned with my own.

Shady Grove Fertility (SGF) Atlanta is proud to announce board certified OB/GYN and board-eligible reproductive endocrinologist Valerie Libby, M.D., M.P.H., FACOG, has joined the practice’s award-winning Atlanta medical team. Dr. Libby will join Atlanta physicians Drs. Desireé McCarthy-Keith, Anne Namnoum, Pavna Brahma, and Mark Perloe, and will begin seeing patients in SGF’s Atlanta – Northside location in late September 2020.

Dr. Libby will provide a full range of state-of-the-art, in-house diagnostic and treatment options for female and male infertility, elective egg freezing, LGBTQ family building, and fertility preservation prior to cancer treatment.

Dr. Libby earned her medical degree at The University of Texas Health Science Center at San Antonio and completed her residency training in Obstetrics and Gynecology at Parkland Hospital, University of Texas at Southwestern Medical Center. Dr. Libby went on to complete her fellowship in Reproductive Endocrinology and Infertility at the University Hospitals Cleveland Medical Center/Case Western Reserve University.

Dr. Libby has published several peer-reviewed scientific manuscripts, book chapters, and review articles in many leading scientific journals in the fields of reproductive endocrinology and infertility. Her specific research interest is fertility preservation and egg freezing. She is a fellow of the American Congress of Obstetrics and Gynecology and a member of numerous medical organizations.

Dr. Libby’s clinical interests include any aspect of female and male infertility, in particular, making advances in in vitro fertilization, oocyte donation, recurrent pregnancy loss, fertility preservation, and polycystic ovary syndrome (PCOS).

“I am honored and thrilled to join SGF Atlanta. The first time I met with SGF, I learned about their core values of integrity, empathy, and increasing access to care—values directly aligned with my own,” says Libby.

SGF Atlanta, who was named Best Reproductive Endocrinology Practice by Kudzu and Top Doctors by Atlanta Magazine, currently has four locations in the greater Atlanta region. Patients also have access to SGF Atlanta’s unique financial options that help make fertility treatment more affordable.

“As a fertility patient myself, I understand the financial burden of IVF,” Libby explains. “SGF mitigates this risk significantly by sharing financial risk with the patients. SGF was one of the first fertility practices to create a refund guarantee program for IVF and donor egg and is constantly maintaining and improving their standards of care with evidence-based practices.”

“We are honored to have Dr. Valerie Libby join the SGF Atlanta medical team. With now five reproductive endocrinologists in the Atlanta region, patients have even more convenient access than ever before to highly specialized fertility care from an esteemed team of physicians,” says Dr. Desireé McCarthy-Keith, Medical Director of SGF Atlanta.

Patients may schedule an appointment with Dr. Libby at SGF’s Atlanta-Northside location by calling 1-877-761-1967 or submit this brief form.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Share article on social media or email:

Maged Hamza, M.D. Joins Physician Partners of America


Maged Hamza, M.D.

Physician Partners of America (PPOA) announces that Maged Hamza, M.D., has joined the company as an interventional pain management specialist in its Jacksonville, Fla., practice. The office is located at 11705 San Jose Blvd, Suite 110, Jacksonville, FL 32223.

Dr. Hamza specializes in treating all pain types, including neck, back, abdominal, pelvic and neuropathy. He is a well-known pioneer in treating chronic pain with spinal cord stimulation and pain pumps, but also utilizes many other minimally invasive modalities, including nerve blocks, radio frequency ablation and injections.

“Chronic pain does not get the same level of attention as other diseases, and patients may go from specialist to specialist seeking relief,” he says. “My patients have seen as many as seven other doctors before they come to me. By then, they are suffering from emotional as well as physical pain.”

A native of Egypt, Dr. Hamza received his Bachelor of Science in Anatomy and Physiology and his medical degree from Cairo University. He completed an internship at the university’s College of Medicine, followed by residencies in Anesthesiology and General Surgery at the University of Arizona College of Medicine in Tucson. He completed a fellowship in Pain Management at the University of Virginia School of Medicine in Charlottesville and served as an assistant professor there.

After four years, he went into private practice and later, moved to the Virginia Commonwealth University School of Medicine in Richmond. He served as the director of VCU’s interventional pain medicine fellowship, Spine Center, interventional pain, and neuromodulation programs for more than a decade. His patient-centric approach earned Dr. Hamza the distinction of being one of Richmond’s “Top Doctors” for five straight years.

Dr. Hamza joins Physician Partners of America – Jacksonville from Eastern Virginia Medical School, where he was a lead investigator researching innovating methods of diagnosing and treating pain.

“I am committed to reducing my patients’ suffering,” he says. “My sincerest desire is to help them back to enjoying a full life again.”

Dr. Hamza is a Diplomat of the American Board of Anesthesiology with a subspecialty in Pain Medicine, and a Diplomat of the American Board of Medical Examiners. He is a member of 15 medical associations including the American Society of Interventional Pain Physicians and the International Spine Intervention Society.

He and his wife have four children. In his spare time, he enjoys tending to his small farm and raising goats and sheep.

Make an appointment with Dr. Hamza by calling (904) 453-7976 or click here

About PPOA:

Physician Partners of America (PPOA) is a national healthcare organization focused on strengthening the doctor-patient relationship and improving patient outcomes. PPOA and its affiliates share a common vision to ensure the well-being of patients and provide its physician partners the opportunity to focus on the practice of medicine. This model allows physicians to be physicians, caring about patients and their needs versus the ever-complex administrative requirements. For more information about Physician Partners of America, visit http://www.physicianpartnersoa.com.

Share article on social media or email:

Immuno-Oncology 360° Launches Newsletter to Raise a Wide Variety of Voices Fighting Cancer


“By adding the IO360° newsletter to our IO360° portfolio, we are able to provide timely insights and ongoing support throughout the year for the Immuno-Oncology community,” said Kate Woda, Conference Director of Immuno-Oncology 360° Group.

The Conference Forum’s Immuno-Oncology 360° group launched their first IO360° newsletter dedicated to addressing advancements of clinical, scientific and business developments in immuno-oncology by highlighting a wide variety of perspectives from all areas of the IO space. The IO360° newsletter will feature extraordinary individuals who contribute to this science and motivate and inspire the wider IO community.

“By adding the IO360° newsletter to our IO360° portfolio, we are able to provide timely insights and ongoing support throughout the year for the Immuno-Oncology community,” said Kate Woda, Conference Director of Immuno-Oncology 360° Group.

The interviews will capture scientist, clinician, operations, patient and investor perspectives, and cover topics ranging from cancer vaccines, checkpoint blockade therapy, the tumor microenvironment, bispecific antibodies, combination therapies, R&D strategies, the clinical trial experience, clinical operations, manufacturing, data management, cell and gene therapy, immune monitoring, CAR-T therapy to solid tumors, the future of IO, personal experiences and more.

The launch interview issue of IO360° features cell therapy pioneer and serial entrepreneur Dr Arie Belldegrun, Executive Chairman and Co-Founder, Allogene Therapeutics and Co-Founder and Senior Managing Director, Vida Ventures.

The inaugural interview issue of IO360° also features Dr Lisa Butterfield, VP, R&D, Parker Institute for Cancer Immunotherapy, Dr Dimitris Skokos, Senior Director, Cancer Immunology Research, Regeneron, Adriana Comprelli, Therapeutic Area Head, Clinical Operations Strategy, BMS, Steve Hamilton, Cancer Veteran, and Dr John Connolly, CSO, Parker Institute of Cancer Immunotherapy.

Immuno-Oncology 360° group presents the IO Combinations 360° and Immuno-Oncology 360° conferences and Immuno-Oncology themed podcasts.

About the Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

They currently offer conferences for pharma/biotech professionals including R&D leaders, CEOs, business development/licensing, medical affairs/safety, chief patient officers/advocates, clinical innovation champions, investors and drug delivery specialists. The company also publishes six newsletters and produces PharmaTalkRadio and virtual events.

Learn more about The Conference Forum at theconferenceforum.org.

Share article on social media or email:

NeoTract Designates Dr. Rajesh Patel as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Rajesh Patel as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Rajesh Patel, M.D., Associated Urological Specialists in Homewood, IL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Patel has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Rajesh Patel as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Physiatrist, Dr. Paul Abend Named NJ Top Doc For Seven Consecutive Years


News Image

Dr. Paul Abend has been reviewed and approved by NJ Top Docs for 2020. This is Dr. Abend’s seventh consecutive year receiving the NJ Top Doc designation.

With over three decades of experience in the field of physiatry and pain management, Dr. Abend continues to excel in his field while treating every patient with compassionate care.

Dr. Abend specializes in neuropathy and is double-board certified in Family Medicine and Physical Medicine and Rehabilitation. His overall goal is to eliminate pain, promote mobility, improve movement potential and provide a better quality of life for each of his patients.

Dr. Abend is currently the Medical Director of Inpatient and Outpatient Services at the Robert Wood Johnson University Hospital (RWJUH) in Rahway, New Jersey. Here he focuses primarily on non-surgical spinal treatments, sports injuries, post cancer survivorship, balance and neuropathy.

To learn more about NJ Top Doc, Dr. Paul Abend, please click here: https://njtopdocs.com/nj-doctors/drabend/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Raybow Pharmaceutical announces new webinar “Safe and Efficient Fluoroalkylations”


Raybow Pharmaceutical Green Chemistry image with Fluorine element

Raybow Pharmaceutical

“We are happy to be able to share our experiences in an effort to further the fluorine chemistry field. The scientific team has been generous in sharing their knowledge,” said Hütten.

On September 16th at 2:00 PM CEST Raybow Pharmaceutical’s Dr. Dirk Hütten will present real world data and case studies from Raybow’s experienced team of scientists. The webinar is titled “Safe and Efficient Fluoroalkylations“.

Fluorine chemistry is an exciting and evolving field in the world of science but is not without its issues.

Raybow Pharmaceutical’s scientific team has exceptional knowledge and experience with Fluoroalkylation reactions. ​In this 45 minute online presentation Dr. Dirk Hütten will present some of the key efficiencies realized through Raybow’s work in the field. The webinar will showcase how Raybow has been able to increase efficiency while overcoming the challenges presented by these reactions. Fluoroalkylation is an important part of Raybow’s green chemistry focus.

This presentation includes a live Q&A where Dr. Hütten will answer questions. The webinar will be recorded for on-demand playback at Raybow.com.

Raybow has pharmaceutical manufacturing facilities in Taizhou and Suzhou in China as well as R&D centers in Taizhou and Hangzhou in China.

Raybow has experienced R&D teams at world class R&D centers in Hangzhou and Taizhou in China as well as Brevard, NC in the United States.

Raybow Pharmaceutical is a global CDMO with team members and facilities in the United States, Europe and China. Raybow Pharma brings client projects from medchem to commercial launch and has developed client NCE’s that are now blockbuster status (USD$1Bill. in prescription sales). Raybow is motivated to create solutions to solve their clients’ chemical development challenges in order to get new life saving and life changing small molecule drugs to market successfully.

Share article on social media or email:

FDAnews Announces —17th Annual Medical Device Quality vCongress, Wednesday, Oct. 7 – Thursday, Oct. 8, 2020


WCG FDAnews

WCG FDAnews

17th Annual Medical Device Quality vCongress

Wednesday, Oct. 7 – Thursday, Oct. 8, 2020

https://www.fdanews.com/mdqc

Register by Sept. 15 and get an additional 10% off the early bird savings by using the promo code MDQCSUMMER10!

Join us on Oct. 7-8 to interact virtually with FDA officials, consultants, lawyers, experts and colleagues — before EU-MDR’s deadline. Register by Sept. 15 and save an additional 10% off the early bird savings for this premier virtual event for device quality and compliance professionals.

A special focus on the new EU Medical Device Regulation (EU-MDR) will ensure compliance in Europe. With the Medical Device Quality vCongress taking place months before the May 2021 EU-MDR deadline, easily fine-tune plans — and strengthen product positions — in advance of these sweeping changes.

The virtual program includes:


  • Impact of new economic operators in the EU-MDR and EU In Vitro Diagnostics Regulation (EU-IVDR) — the key to business success in the EU
  • Implementation of the clinical evaluation (EU-MDR) or performance evaluation process (EU-IVDR) — what one must know to obtain a CE Mark
  • QMS under EU-MDR and EU-IVDR — create a foolproof QMS
  • Complaint reporting — save time and money by avoiding resubmission requests with U.S. medical device reporting (MDR) and EU-MDR’s/IVDR’s new manufacturer’s incident report (MIR)
  • Corrective actions — U.S. and EU perspectives, including EU-MDR/IVDR field safety corrective actions (FSCAs), field safety notice (FSN) and other reports one must file to ensure compliance
  • Risk management systems (RMS) under ISO 14971:2019, including European norms — practical ways to implement both in one unified system
  • Postmarket surveillance (PMS) in EU-MDR/IVDR — take a more proactive approach and implement a compliant system


This virtual event provides all the benefits of a live Medical Device Quality Congress but allows one to attend remotely.

Register now and save an additional 10% off the early bird price with promo code MDQCSUMMER10: After Sept. 15, this special price will end.

Multi-attendee discounts available!

Significant tuition discounts are available for teams of two or more from the same company.

Conference Details:

17th Annual Medical Device Quality vCongress

Wednesday, Oct. 7 – Thursday, Oct. 8, 2020

https://www.fdanews.com/mdqc

Tuition:

Early Bird Pricing: $597 (available until Sept. 15, 2020)

Regular Pricing: $697 (after Sept. 15, 2020)

Significant team discounts are available.

Easy Ways to Register:

Online: https://www.fdanews.com/mdqc

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Jackson House is Making Residential Mental Health Treatment More Accessible


The ongoing coronavirus pandemic is taking a toll on American’s mental health. A recent poll by the Kaiser Family Foundation found, since the outbreak started, 56 percent of adults in the U.S. have experienced negative effects on their mental health. With the need for mental health services growing, Jackson House, a voluntary, residential treatment program with several locations across southern California, is working to remove barriers and make treatment more accessible.

“Our mental health is just as important as our physical health,” said Dr. Bruce Figuered, President of Jackson House. “While stress is heightened for everyone at the moment, it has been particularly difficult for individuals who do not have healthy coping skills or suffer from underlying mental health conditions. If you feel like you’ve been struggling, it is important to reach out for help.”

Unfortunately, a study by the National Alliance on Mental Illness revealed many Americans have trouble finding access to mental healthcare services. High out-of-pocket costs, lack of in-network treatment options and a provider shortage were cited as key barriers in the report. Jackson House has actively been working with California health insurance companies to remove some of these obstacles and make residential mental health treatment more accessible.

Cost is one of the biggest concerns for individuals seeking treatment. To make mental healthcare more affordable for Californians, Jackson House has worked to become in-network with 11 different health insurance plans, including Aetna, Beacon/Value Options, Blue Cross/Anthem, Blue Shield/Magellan, Cigna, Healthnet/MHN, Humana and Kaiser.

“We do not want money to be the reason someone doesn’t reach out for help,” said Dr. Figuered. “Mental illness is treatable and people should not have to suffer needlessly. With the right treatment plan, support and development of new life skills, our team believes everyone can improve their quality of life.”

Dr. Figuered encourages individuals who are worried about the cost of mental health treatment to call their insurance company directly to ask about in-network options and understand the cost of care. Insurance companies can also provide their clients with a list of providers in their area. Californians can also call Jackson House directly if they are interested in seeking residential mental health treatment.

###

Jackson House was built to fill a critical gap in the healthcare system. The company recognized there were outpatient treatment options and locked, inpatient facilities but nothing in the middle. Jackson House allows people to receive around the clock mental health treatment voluntarily, on their own terms. The program is built around evidenced based care and customized to meet each client’s unique needs. Jackson House helps clients manage the symptoms of their mental illness, provides tools for recovery and teaches the life skills necessary to thrive. Learn more by visiting http://www.jacksonhousecares.com.

Share article on social media or email: